Business · Week of Nov 9, 2026
CorMedix to buy Heron assets, Apotex raises guidance: business releases
Elmet Group Co., loanDepot, TTEC, Jaguar Mining, SKYX and Digi Power X also reported; refinancing, acquisitions and guidance updates ran through the week.
Third-quarter earnings dominated the week's business releases. Apotex Health Corp. raised its fiscal 2027 guidance, and The Elmet Group Co. reported revenue up 55.6% with an order backlog of approximately $347.4 million. Jaguar Mining posted higher adjusted net income on gold sales. loanDepot reported a wider loss, and TTEC reported lower revenue but higher operating income.
Balance sheets and deals were a second thread. loanDepot says it is pursuing options to refinance or extend upcoming debt maturities. TTEC extended its Credit Facility to November 2028, and Digi Power X expects to close a proposed $200 million credit facility. CorMedix agreed to acquire substantially all of Heron Therapeutics' assets, backed by a new term loan. SKYX closed its merger with Deako, and Elmet announced investments, a joint venture commitment and an acquisition.

Apotex Health Corp.
Apotex Delivers Strong Second Quarter 2027 Results and Raises FY2027 Guidance
Apotex Health Corp. reported Q2 revenue of $853 million and Adjusted EBITDA of $280 million. It raised fiscal 2027 guidance to revenue growth of 9-10% and an Adjusted EBITDA margin of about 31%. The company says Canada revenue rose about 14%, helped by its first-to-market semaglutide launch, while U.S. revenue excluding VLLP fell about 3%.
loanDepot, Inc.
loanDepot announces third quarter 2026 financial results
loanDepot reported a third-quarter 2026 net loss of $28.7 million on revenue of $307.1 million, wider than the $6.6 million loss in the second quarter. The company says an MSR sale and discounted note repurchases cut net debt obligations by approximately $114 million, and it is pursuing financing alternatives for upcoming maturities.
Jaguar Mining, Inc.
Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Jaguar Mining reported Q3 revenue up 79% to $60.8 million and Adjusted Net Income of $13.0 million, while all-in sustaining costs rose to $3,164 per ounce. The company says it is more likely to reach the lower end of its 2026 production guidance and plans to resubmit its Onças de Pitangui licence application after a denial on October 30, 2026.
Elmet Group Co.
The Elmet Group Co. Reports Third Quarter 2026 Results
The Elmet Group Co. reported third fiscal quarter revenue up 55.6% to approximately $79.6 million and net income of approximately $8.3 million, with gross margin rising to 31.3%. Its open order backlog rose 298% year on year to approximately $347.4 million. The CEO cited a joint venture commitment of approximately $150 million, a $125 million investment in Masan High-Tech Materials Corporation and the planned acquisition of Osram's metal production operations in Germany.
SKYX Platforms Corp.
SKYX Reports Record Revenue of $25.7M in Q-3 2026 Compared to $23.9M in Q-3 2025 and 11 Consecutive Quarters of Growth YoY
SKYX Platforms Corp. reported Q3 2026 revenue of $25.7 million, up 7.4%, and a net loss of $6.4 million, narrower than a year earlier. The company completed its merger with Deako on October 13, 2026, issuing 25,000,000 shares under a 12-month lock-up, and says its builder programs are expected to cover more than 210,000 units.
CorMedix Inc.
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
CorMedix agreed to acquire substantially all of Heron Therapeutics' assets, including ZYNRELEF, APONVIE, CINVANTI and SUSTOL, for upfront consideration the companies value at approximately $222.6 million, plus up to $55 million in earn-outs. The deal is expected to close in the first quarter of 2027, subject to Heron stockholder approval and antitrust clearance, and is supported by a $150 million term loan facility from funds managed by Pharmakon Advisors.
TTEC Holdings, Inc.
TTEC Announces Third Quarter 2026 Financial Results and
TTEC Holdings reported third-quarter 2026 revenue down 5.2 percent to $492.2 million, while GAAP income from operations rose to $23.3 million and net debt fell to $743.6 million. The company guided full-year 2026 revenue of $1,940M to $1,990M and extended its Credit Facility to November 2028.
Digi Power X Inc.
DIGI POWER X INC.
Digi Power X reported Q3 revenue of $12.25 million, up 85% from the prior quarter, with AI revenue at 46% of the total. It reported net income of $1.0 million, which the company says was materially supported by digital currency and warrant valuation gains. The company targets an annualized revenue run-rate of about $250 million to $300 million by the end of Q3 2027, subject to financing, and expects to close a proposed $200 million credit facility in Q4 2026.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Business News Talks reporting.